InvestorsHub Logo
Followers 62
Posts 7597
Boards Moderated 1
Alias Born 01/02/2003

Re: cloudera post# 424988

Tuesday, 06/04/2024 6:02:11 PM

Tuesday, June 04, 2024 6:02:11 PM

Post# of 428507
cloudera...I assume that Amarin might continue to market branded Vascepa while marketing the same product as a generic V....BUT marketing generic V with a different label from Vascepa, calling the generic V Icosapentethyl, but that is just an off the cuff guess.

The generic companies use an inferior capsule, which causes more oxidization of the EPA, but I'm not sure how Amarin would handle that issue.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News